Edition:
United States

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

7.35USD
16 Feb 2018
Change (% chg)

$0.10 (+1.38%)
Prev Close
$7.25
Open
$7.35
Day's High
$7.35
Day's Low
$7.35
Volume
1
Avg. Vol
2,661
52-wk High
$9.25
52-wk Low
$5.00

Chart for

About

ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle,... (more)
No analyst recommendations are available for .

Overall

Beta: 1.01
Market Cap(Mil.): $37.23
Shares Outstanding(Mil.): 5.06
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-ImmuCell Announces Q4 Loss Per Share $0.04

* IMMUCELL ANNOUNCES PRELIMINARY FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017

Feb 08 2018

BRIEF-ImmuCell Appoints Two New Members To Its Board Of Directors

* IMMUCELL APPOINTS TWO NEW MEMBERS TO ITS BOARD OF DIRECTORS

Jan 30 2018

BRIEF-ImmuCell Corp Announces Pricing Of $3 Mln Public Offering Of Common Shares

* IMMUCELL CORPORATION ANNOUNCES PRICING OF $3 MILLION PUBLIC OFFERING OF COMMON SHARES

Dec 19 2017

BRIEF-Immucell Q3 loss per share $0.07

* Immucell announces financial results for third quarter of 2017

Nov 13 2017

BRIEF-ImmuCell announces expansion of sales and marketing team

* ImmuCell Corp - ‍during Q4 of 2017, company expects to achieve regulatory approval of First Defense Tri-Shield​

Sep 13 2017

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $56.29 +0.30
Pfizer Inc. (PFE.N) $36.26 +0.55
Eli Lilly and Co (LLY.N) $78.97 +0.95

Earnings vs. Estimates

No consensus analysis data available.